133 related articles for article (PubMed ID: 19085374)
1. Anti-inflammatory effects of besifloxacin, a novel fluoroquinolone, in primary human corneal epithelial cells.
Zhang JZ; Cavet ME; Ward KW
Curr Eye Res; 2008 Nov; 33(11):923-32. PubMed ID: 19085374
[TBL] [Abstract][Full Text] [Related]
2. Besifloxacin, a novel fluoroquinolone antimicrobial agent, exhibits potent inhibition of pro-inflammatory cytokines in human THP-1 monocytes.
Zhang JZ; Ward KW
J Antimicrob Chemother; 2008 Jan; 61(1):111-6. PubMed ID: 17965029
[TBL] [Abstract][Full Text] [Related]
3. BOL-303242-X, a novel selective glucocorticoid receptor agonist, with full anti-inflammatory properties in human ocular cells.
Zhang JZ; Cavet ME; VanderMeid KR; Salvador-Silva M; López FJ; Ward KW
Mol Vis; 2009 Dec; 15():2606-16. PubMed ID: 20011631
[TBL] [Abstract][Full Text] [Related]
4. Anti-inflammatory and anti-oxidative effects of the green tea polyphenol epigallocatechin gallate in human corneal epithelial cells.
Cavet ME; Harrington KL; Vollmer TR; Ward KW; Zhang JZ
Mol Vis; 2011 Feb; 17():533-42. PubMed ID: 21364905
[TBL] [Abstract][Full Text] [Related]
5. Anti-inflammatory effects of moxifloxacin on activated human monocytic cells: inhibition of NF-kappaB and mitogen-activated protein kinase activation and of synthesis of proinflammatory cytokines.
Weiss T; Shalit I; Blau H; Werber S; Halperin D; Levitov A; Fabian I
Antimicrob Agents Chemother; 2004 Jun; 48(6):1974-82. PubMed ID: 15155187
[TBL] [Abstract][Full Text] [Related]
6. Anti-inflammatory effects of moxifloxacin on IL-8, IL-1beta and TNF-alpha secretion and NFkappaB and MAP-kinase activation in human monocytes stimulated with Aspergillus fumigatus.
Shalit I; Halperin D; Haite D; Levitov A; Romano J; Osherov N; Fabian I
J Antimicrob Chemother; 2006 Feb; 57(2):230-5. PubMed ID: 16352735
[TBL] [Abstract][Full Text] [Related]
7. Ocular pharmacokinetics/pharmacodynamics of besifloxacin, moxifloxacin, and gatifloxacin following topical administration to pigmented rabbits.
Proksch JW; Ward KW
J Ocul Pharmacol Ther; 2010 Oct; 26(5):449-58. PubMed ID: 20874668
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of besifloxacin in a rabbit model of methicillin-resistant Staphylococcus aureus keratitis.
Sanders ME; Norcross EW; Moore QC; Shafiee A; Marquart ME
Cornea; 2009 Oct; 28(9):1055-60. PubMed ID: 19724203
[TBL] [Abstract][Full Text] [Related]
9. Curcumin protects against hyperosmoticity-induced IL-1beta elevation in human corneal epithelial cell via MAPK pathways.
Chen M; Hu DN; Pan Z; Lu CW; Xue CY; Aass I
Exp Eye Res; 2010 Mar; 90(3):437-43. PubMed ID: 20026325
[TBL] [Abstract][Full Text] [Related]
10. Moxifloxacin inhibits cytokine-induced MAP kinase and NF-kappaB activation as well as nitric oxide synthesis in a human respiratory epithelial cell line.
Werber S; Shalit I; Fabian I; Steuer G; Weiss T; Blau H
J Antimicrob Chemother; 2005 Mar; 55(3):293-300. PubMed ID: 15659543
[TBL] [Abstract][Full Text] [Related]
11. Cytokine, chemokine, and adhesion molecule expression mediated by MAPKs in human corneal fibroblasts exposed to poly(I:C).
Liu Y; Kimura K; Yanai R; Chikama T; Nishida T
Invest Ophthalmol Vis Sci; 2008 Aug; 49(8):3336-44. PubMed ID: 18660424
[TBL] [Abstract][Full Text] [Related]
12. Comparative efficacy of besifloxacin and other fluoroquinolones in a prophylaxis model of penicillin-resistant Streptococcus pneumoniae rabbit endophthalmitis.
Norcross EW; Sanders ME; Moore Q; Sanfilippo CM; Hesje CK; Shafiee A; Marquart ME
J Ocul Pharmacol Ther; 2010 Jun; 26(3):237-43. PubMed ID: 20565309
[TBL] [Abstract][Full Text] [Related]
13. Mapracorat, a novel selective glucocorticoid receptor agonist, inhibits hyperosmolar-induced cytokine release and MAPK pathways in human corneal epithelial cells.
Cavet ME; Harrington KL; Ward KW; Zhang JZ
Mol Vis; 2010 Sep; 16():1791-800. PubMed ID: 20824100
[TBL] [Abstract][Full Text] [Related]
14. Innate immune response of corneal epithelial cells to Staphylococcus aureus infection: role of peptidoglycan in stimulating proinflammatory cytokine secretion.
Kumar A; Zhang J; Yu FS
Invest Ophthalmol Vis Sci; 2004 Oct; 45(10):3513-22. PubMed ID: 15452057
[TBL] [Abstract][Full Text] [Related]
15. Quercetin disrupts tyrosine-phosphorylated phosphatidylinositol 3-kinase and myeloid differentiation factor-88 association, and inhibits MAPK/AP-1 and IKK/NF-κB-induced inflammatory mediators production in RAW 264.7 cells.
Endale M; Park SC; Kim S; Kim SH; Yang Y; Cho JY; Rhee MH
Immunobiology; 2013 Dec; 218(12):1452-67. PubMed ID: 23735482
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of besifloxacin in an early treatment model of methicillin-resistant Staphylococcus aureus keratitis.
Sanders ME; Moore QC; Norcross EW; Shafiee A; Marquart ME
J Ocul Pharmacol Ther; 2010 Apr; 26(2):193-8. PubMed ID: 20334537
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-1beta induces MMP-9 expression via p42/p44 MAPK, p38 MAPK, JNK, and nuclear factor-kappaB signaling pathways in human tracheal smooth muscle cells.
Liang KC; Lee CW; Lin WN; Lin CC; Wu CB; Luo SF; Yang CM
J Cell Physiol; 2007 Jun; 211(3):759-70. PubMed ID: 17311279
[TBL] [Abstract][Full Text] [Related]
18. The therapeutic effect of DA-6034 on ocular inflammation via suppression of MMP-9 and inflammatory cytokines and activation of the MAPK signaling pathway in an experimental dry eye model.
Seo MJ; Kim JM; Lee MJ; Sohn YS; Kang KK; Yoo M
Curr Eye Res; 2010 Feb; 35(2):165-75. PubMed ID: 20136427
[TBL] [Abstract][Full Text] [Related]
19. Corticosteroid and doxycycline suppress MMP-9 and inflammatory cytokine expression, MAPK activation in the corneal epithelium in experimental dry eye.
De Paiva CS; Corrales RM; Villarreal AL; Farley WJ; Li DQ; Stern ME; Pflugfelder SC
Exp Eye Res; 2006 Sep; 83(3):526-35. PubMed ID: 16643899
[TBL] [Abstract][Full Text] [Related]
20. Biochanin-A, an isoflavon, showed anti-proliferative and anti-inflammatory activities through the inhibition of iNOS expression, p38-MAPK and ATF-2 phosphorylation and blocking NFκB nuclear translocation.
Kole L; Giri B; Manna SK; Pal B; Ghosh S
Eur J Pharmacol; 2011 Feb; 653(1-3):8-15. PubMed ID: 21147093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
